{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:22:33Z","timestamp":1794608553724,"version":"4.9.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.eprac.2024.10.002","type":"journal-article","created":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T15:11:55Z","timestamp":1728745915000},"page":"19-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Examining the Influence of the Route of Administration and Dose of Estradiol on Serum Estradiol and Testosterone Levels in Feminizing Gender-Affirming Hormone Therapy"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5283-3130","authenticated-orcid":false,"given":"Daniel J.","family":"Slack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Di Via Ioschpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Saturno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sky","family":"Kihuwa-Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uchechukwu O.","family":"Amakiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subha","family":"Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Safer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.eprac.2024.10.002_bib1","first-page":"S1","article-title":"Standards of care for the health of transgender and gender diverse people, version 8","volume":"23","author":"Coleman","year":"2022","journal-title":"Int J Transgend Health"},{"issue":"11","key":"10.1016\/j.eprac.2024.10.002_bib2","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an endocrine society clinical practice guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.eprac.2024.10.002_bib3","first-page":"1999","article-title":"Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence","volume":"11","author":"Wierckx","year":"2014","journal-title":"J\u00a0Sex Med"},{"issue":"1","key":"10.1016\/j.eprac.2024.10.002_bib4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1210\/er.2018-00011","article-title":"Endocrinology of transgender medicine","volume":"40","author":"T'Sjoen","year":"2019","journal-title":"Endocr Rev"},{"issue":"43","key":"10.1016\/j.eprac.2024.10.002_bib5","first-page":"725","article-title":"Hormonal gender reassignment treatment for gender dysphoria","volume":"117","author":"Meyer","year":"2020","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"10.1016\/j.eprac.2024.10.002_bib6","doi-asserted-by":"crossref","first-page":"ITC1","DOI":"10.7326\/AITC201907020","article-title":"Care of the transgender patient","volume":"171","author":"Safer","year":"2019","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.eprac.2024.10.002_bib7","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.eprac.2024.05.008","article-title":"The use of injectable estradiol in transgender and gender diverse adults: a scoping review of dose and serum estradiol levels","volume":"30","author":"Rothman","year":"2024","journal-title":"Endocr Pract"},{"issue":"2","key":"10.1016\/j.eprac.2024.10.002_bib8","first-page":"55","article-title":"Hormone therapy in transgender adults is safe with provider supervision; A review of hormone therapy sequelae for transgender individuals","volume":"2","author":"Weinand","year":"2015","journal-title":"J\u00a0Clin Transl Endocrinol"},{"issue":"1","key":"10.1016\/j.eprac.2024.10.002_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4158\/EP-2020-0414","article-title":"Serum hormone concentrations in transgender individuals receiving gender-affirming hormone therapy: a longitudinal retrospective cohort study","volume":"27","author":"Chantrapanichkul","year":"2021","journal-title":"Endocr Pract"},{"issue":"5","key":"10.1016\/j.eprac.2024.10.002_bib10","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/jama.2012.165234","article-title":"Management of transgenderism","volume":"309","author":"Spack","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.eprac.2024.10.002_bib11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4158\/EP-2017-0116","article-title":"Testosterone levels achieved by medically treated transgender women in a United States endocrinology clinic cohort","volume":"24","author":"Liang","year":"2018","journal-title":"Endocr Pract"},{"key":"10.1016\/j.eprac.2024.10.002_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.eprac.2024.08.014","article-title":"Evaluating the risk of venous thromboembolism in transfeminine and gender diverse people: a retrospective analysis","author":"Slack","year":"2024","journal-title":"Endocr Pract"},{"key":"10.1016\/j.eprac.2024.10.002_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpobgyn.2022.102297","article-title":"Genital gender-affirming surgery for transgender women","volume":"86","author":"van der Sluis","year":"2023","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.eprac.2024.10.002_bib14","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/26895269.2020.1749921","article-title":"Orchiectomy in transgender individuals: a motivation analysis and report of surgical outcomes","volume":"21","author":"van der Sluis","year":"2020","journal-title":"Int J Transgend Health"},{"issue":"2","key":"10.1016\/j.eprac.2024.10.002_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0163-7258(81)90082-6","article-title":"Assay of estrogens","volume":"12","author":"Abraham","year":"1981","journal-title":"Pharmacol Ther"},{"issue":"13","key":"10.1016\/j.eprac.2024.10.002_bib16","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.steroids.2008.05.002","article-title":"Testosterone and estradiol assays: current and future trends","volume":"73","author":"Demers","year":"2008","journal-title":"Steroids"},{"issue":"Pt A","key":"10.1016\/j.eprac.2024.10.002_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.steroids.2014.08.009","article-title":"Estradiol assays--The path ahead","volume":"99","author":"Ketha","year":"2015","journal-title":"Steroids"},{"issue":"8","key":"10.1016\/j.eprac.2024.10.002_bib18","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.steroids.2007.05.003","article-title":"Superiority of gas chromatography\/tandem mass spectrometry assay (GC\/MS\/MS) for estradiol for monitoring of aromatase inhibitor therapy","volume":"72","author":"Santen","year":"2007","journal-title":"Steroids"},{"issue":"1","key":"10.1016\/j.eprac.2024.10.002_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1210\/jc.2007-1809","article-title":"Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience","volume":"93","author":"Gooren","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2024.10.002_bib20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1006\/meth.2000.0974","article-title":"Bioassays of gonadotropins","volume":"21","author":"Christin-Maitre","year":"2000","journal-title":"Methods"},{"key":"10.1016\/j.eprac.2024.10.002_bib21","first-page":"109","article-title":"Assays for LH, FSH, and prolactin","volume":"324","author":"Wheeler","year":"2006","journal-title":"Methods Mol Biol"},{"issue":"3","key":"10.1016\/j.eprac.2024.10.002_bib22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cps.2018.03.003","article-title":"Hormonal management for transfeminine individuals","volume":"45","author":"Abramowitz","year":"2018","journal-title":"Clin Plast Surg"},{"issue":"4","key":"10.1016\/j.eprac.2024.10.002_bib23","first-page":"272","article-title":"Assessing and addressing the risk of venous thromboembolism across the spectrum of gender affirming care: a review","volume":"29","author":"Arrington-Sanders","year":"2023","journal-title":"Endocr Pract"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X24007936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X24007936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T02:01:30Z","timestamp":1736301690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X24007936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1530891X24007936"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2024.10.002","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Examining the Influence of the Route of Administration and Dose of Estradiol on Serum Estradiol and Testosterone Levels in Feminizing Gender-Affirming Hormone Therapy","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2024.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}